Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedUpdated operating status notice and new version (v3.2.0), replacing the previous v3.1.0. The page now provides current guidance on NIH Clinical Center operations and references official status sources.SummaryDifference13%

- Check31 days agoChange DetectedThe page now lists revision v3.1.0 as the current version, replacing v3.0.2.SummaryDifference0.3%

- Check45 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' control was removed. No changes to core content, pricing, stock availability, or time-slot availability.SummaryDifference0.8%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%

- Check59 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while removing specific location details such as state, country, and city information.SummaryDifference9%

- Check74 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.